Zevra Therapeutics

ZVRA - Zevra TherapeuticsFinancials

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

Complete and updated financials table with all primary indicators: Net Income, Revenue, EBITDA, Margin, ROE, Dividends

Year
12/2016
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2017
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2018
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2019
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2020
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2021
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2022
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2023
27
-49
-
L
L
62
L
-25
-
-39
-0
28
-40
-3
0
-
-
12/2024
24
-81
-
L
L
40
L
-10
-
-85
0
82
-85
0
0
-
-
12/2025
106
-59
-
78%
1.5
155
54%
-129
-
-14
-1
12
-15
0
0
-
-